Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 176 - 200 of 10939 in total
Propoxycaine is a local anesthetic of the ester type that has a rapid onset of action and a longer duration of action than procaine hydrochloride . This drug was removed from the US market in 1996. Although no longer available in the United States, this medication was used in combination...
Approved
Matched Description: … Propoxycaine is a local anesthetic of the ester type that has a rapid onset of action and a longer duration …
Scopolamine is a tropane alkaloid isolated from members of the Solanaceae family of plants, similar to atropine and hyoscyamine, all of which structurally mimic the natural neurotransmitter acetylcholine.[A228423, A228763] Scopolamine was first synthesized in 1959, but to date, synthesis remains less efficient than extracting scopolamine from plants. As an acetylcholine...
Approved
Investigational
Matched Synonyms: … alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester …
Matched Description: … [A228763] As an acetylcholine analogue, scopolamine can antagonize muscarinic acetylcholine receptors ... [A228773, L31578] Scopolamine was first approved by the FDA on December 31, 1979, and is currently ... anticholinergic effects, scopolamine is being investigated for diverse therapeutic applications; currently, it is approved
Selenium is a trace metal in the human body particularly important as a component of glutathione peroxidase, an important enzyme in the prevention of cellular damage by free radicals and reactive oxygen species [FDA Label]
Approved
Investigational
Vet approved
Matched Description: … is a trace metal in the human body particularly important as a component of glutathione peroxidase, an
Matched Products: … Selenious Acid
Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure. Trials were halted in the U.S., but the drug is used in various countries.
Approved
Investigational
Cyanocobalamin (commonly known as Vitamin B12) is a highly complex, essential vitamin, owing its name to the fact that it contains the mineral, cobalt. This vitamin is produced naturally by bacteria , and is necessary for DNA synthesis and cellular energy production. Vitamin B12 has many forms, including the cyano-,...
Approved
Nutraceutical
Matched Description: … This drug was initially approved by the FDA in 1942 [FDA label]. …
Matched Mixtures name: … PLASVIT AN INYECTABLE ... New Chapter's D'adamo 4 Your Type Multiple for Type O ... and Succinic Acid
Matched Categories: … Vitamin B12 and Folic Acid ... iron, vitamin B12 and folic acid
A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
Approved
Investigational
Vet approved
Casirivimab is a monoclonal antibody combined with Imdevimab in Regeneron's antibody cocktail known as REGN-COV2 for the treatment of COVID-19. This drug is a combination of antibodies derived from humanized VelocImmune® mice in addition to blood samples from patients who have recovered from COVID-19. These antibodies have been formulated to...
Approved
Experimental
Matched Description: … [L23524] In November 2021, the same indication was approved by the EMA. ... investigational recombinant human IgG1 monoclonal antibodies that, at this time, are not officially approved
Matched Categories: … Approved Treatments for COVID-19 …
Magnesium is classified as an alkaline earth metal and has 2 hydration shells. The element can be found in abundance in the hydrosphere and in mineral salts such as dolomite and magnesium carbonate. Common dietary sources of magnesium include nuts (cashews, peanuts, almonds), beans, bananas, apples, carrots, broccoli, and leafy...
Approved
Experimental
Investigational
Matched Description: … Magnesium is classified as an alkaline earth metal and has 2 hydration shells. ... [A188120,L2601] Magnesium is an important enzyme cofactor and is essential to several metabolic processes ... [A32810] Despite the importance of magnesium and its availability via several food sources, an estimated …
Matched Mixtures name: … Calcium Folic Acid Plus D Chewable …
Matched Products: … Kordel’s Magnesium Amino Acid Chelate 750 Capsules …
The structure of adenosine was first described in 1931, though the vasodilating effects were not described in literature until the 1940s. Adenosine is indicated as an adjunct to thallium-201 in myocardial perfusion scintigraphy, though it is rarely used in this indication, having largely been replaced by dipyridamole and [regadenson].[A229833,A229838] Adenosine...
Approved
Investigational
Matched Description: … [A229828] Adenosine is indicated as an adjunct to thallium-201 in myocardial perfusion scintigraphy,[ …
Matched Mixtures name: … Dr. sunmi care Duel Hyaluronic Acid Essence ... Jayjun Collagen Skin Fit Mask Step 01 Hyaluronic Acid Essence …
Matched Products: … An Adc Sp F ... Mizon Hyaluronic Acid 100 …
Nitric oxide or Nitrogen monoxide is a chemical compound with chemical formula NO. This gas is an important signaling molecule in the body of mammals including humans and is an extremely important intermediate in the chemical industry. It is also a toxic air pollutant produced by automobile engines and power...
Approved
Matched Description: … This gas is an important signaling molecule in the body of mammals including humans and is an extremely …
Matched Products: … roots extract Mesoporous Silica Nanoparticle Zinc) Nitric Oxide, Dexpanthenol, Niacinamide, Salicylic acid ... roots extract Mesoporous Silica Nanoparticle, Zinc) Nitric Oxide, Dexpanthenol, Niacinamide, Salicylic acid
Withdrawn from the Canadian, US, and UK markets in 1998 due to genotoxicity.
Approved
Investigational
Withdrawn
Empagliflozin is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), the transporters primarily responsible for the reabsorption of glucose in the kidney. It is used clinically as an adjunct to diet and exercise, often in combination with other drug therapies,[L13673,L13679,L11479] for the management of type 2 diabetes mellitus. The first known inhibitor...
Approved
Matched Description: … therapies,[L13673,L13679,L11479] for the management of type 2 diabetes mellitus. ... Empagliflozin is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), the transporters primarily ... [A203453] It is used clinically as an adjunct to diet and exercise, often in combination with other drug …
Olipudase alfa is recombinant human acid sphingomyelinase. It is the first and only enzyme replacement therapy in the world for the treatment of Acid Sphingomyelinase Deficiency (ASMD), also known as Niemann–Pick disease. ASMD is a rare lysosomal storage disease caused by mutations in the SMPD1 gene, leading to a deficiency...
Approved
Investigational
Matched Description: … [A251590] It was later approved by the European Commission on June 28, 2022 [L42740] and by the FDA on ... Olipudase alfa is recombinant human acid sphingomyelinase. ... [A251590] It is the first and only enzyme replacement therapy in the world for the treatment of Acid
Pitavastatin, also known as the brand name product Livalo, is a lipid-lowering drug belonging to the statin class of medications. By inhibiting the endogenous production of cholesterol within the liver, statins lower abnormal cholesterol and lipid levels and ultimately reduce the risk of cardiovascular disease. More specifically, statin medications competitively...
Approved
Matched Iupac: … (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
Matched Description: … Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an ... cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type ... hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is...
Approved
Investigational
Matched Description: … A type I interferon consisting of 165 amino acid residues with lysine in position 23. ... An oral form is being developed by Amarillo Biosciences. ... It is used extensively as an antiviral or antineoplastic agent. …
Matched Categories: … Interferon Type I …
Ibrexafungerp, also known as SCY-078 or MK-3118, is a novel enfumafungin derivative oral triterpene antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known as a vaginal yeast infection.[A235384,L34349] It was developed out of a need to treat fungal infections that may have become resistant to echinocandins or azole...
Approved
Investigational
Matched Iupac: … 1H-1,2,4-triazol-1-yl]-17-oxapentacyclo[13.3.3.0^{1,14}.0^{2,11}.0^{5,10}]henicos-2-ene-6-carboxylic acid
Matched Description: … Ibrexafungerp, also known as SCY-078 or MK-3118, is a novel enfumafungin derivative oral triterpene antifungal approved
Interferon alpha 2b (human leukocyte clone hif-sn 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent.
Approved
Matched Description: … A type I interferon consisting of 165 amino acid residues with arginine in position 23. ... It is used extensively as an antiviral or antineoplastic agent. …
Matched Categories: … Interferon Type I …
Pramlintide is a relatively new adjunct treatment for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals. It is derived from amylin, a hormone that is released into the bloodstream, in a similar pattern as insulin, after a meal. Like insulin, amylin is deficient in individuals with diabetes.
Approved
Investigational
Matched Description: … Pramlintide is a relatively new adjunct treatment for diabetes (both type 1 and 2), developed by Amylin …
A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of atropine. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used in the form of eye drops for mydriatic effect. [PubChem]
Approved
Matched Description: … It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms …
Almasilate is a buffering antacid that has been used in peptic ulcers and dyspepsia. It is a crystalline polyhydrate of aluminium/magnesium silicate and mediates its buffering activity by binding hydrogen ions within the polymer. However its therapeutic efficacy is not comparable to other approved antacids, as it is no more...
Approved
Experimental
Matched Description: … in neutralizing acid and binding bile salts than other conventional antacids [A27138]. ... However its therapeutic efficacy is not comparable to other approved antacids, as it is no more effective …
Matched Categories: … Gastric Acid Lowering Agents ... Drugs for Acid Related Disorders …
Metformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the management of type II diabetes.[L12207,A176173] Metformin is considered an antihyperglycemic drug because it lowers blood glucose concentrations in type II diabetes without causing hypoglycemia. It is commonly described as an "insulin sensitizer", leading to a decrease in insulin...
Approved
Matched Description: … [A36559] Metformin was first approved in Canada in 1972,[A36552] and received subsequent FDA approval ... for obese patients type II diabetes. ... concentrations in type II diabetes without causing hypoglycemia. …
Enasidenib is an orally available treatment for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with specific mutations in the isocitrate dehydrogenase 2 (IDH2) gene, which is a recurrent mutation detected in 12-20% of adult patients with AML [A20344, A20345]. Patients eligible for this treatment...
Approved
Investigational
Matched Description: … First developed by Agios Pharmaceuticals and licensed to Celgene, enasidenib was approved by U.S. ... Enasidenib is an orally available treatment for the treatment of adult patients with relapsed or refractory ... This small molecule acts as an allosteric inhibitor of mutant IDH2 enzyme to prevent cell growth, and …
Albiglutide is a glucagon-like peptide-1 agonist (GLP-1) biologic drug indicated in the treatment of type 2 diabetes. It is marketed under the brands Eperzan and Tanzeum by GSK (GlaxoSmithKline). It is a dipeptidyl peptidase-4-resistant glucagon-like peptide-1 dimer fused to human albumin. Albiglutide was approved on April 15, 2014 by the...
Approved
Matched Description: … Albiglutide was approved on April 15, 2014 by the FDA. ... Albiglutide is a glucagon-like peptide-1 agonist (GLP-1) biologic drug indicated in the treatment of type
Intrinsic factor (IF), also known as gastric intrinsic factor (GIF), is a glycoprotein produced by the parietal cells of the stomach that is necessary for the absorption of vitamin B12 (cobalamin) later on in the small intestine. When vitamin B12 is provided in combination with intrinsic factor, intrinsic factor reduces...
Approved
Experimental
Matched Description: … Intrinsic factor is not currently available in any FDA or Health Canada approved products. ... Hematogen in combination with cyanocobalamin (synthetic Vitamin B12), ferrous fumarate, and ascorbic acid
Matched Mixtures name: … Iron Aspartate, Glycinate, Ascorbic Calcium, Vitamin B12, Calcium Threonate and Succinic Acid
Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women. Bremelanotide does not interact with alcohol. The mechanism by which bremelanotide's action on receptors translates to a clinical effect is still unknown. Bremelanotide was first described in the literature in 2003 when it...
Approved
Investigational
Matched Description: … Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal …
Matched Categories: … Receptor, Melanocortin, Type 3, agonists ... Receptor, Melanocortin, Type 4, agonists …
Displaying drugs 176 - 200 of 10939 in total